Elevance Health Inc.
Buzzing onWhy it's trendingX mentions rising faster than the marketRecent insider buying clusterBacked by solid revenue growth$400.32+0.5%YTD+7.8%1Y+35.5%
Mentions · last 7 days
54-2%
Price updated 1d ago·X counts updated 2d ago
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $ELV, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $ELV.
Medical - Healthcare Plans
No material change from last week — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers.
What this means for $ELV
Partial — Large managed care company providing health insurance and related benefits to ~118 million individuals across commercial, Medicare, and Medicaid segments; partial earnings exposure to medical - healthcare plans demand dynamics through its product portfolio.
Top industry ETF
$IHFiShares U.S. Healthcare Providers ETF
+17.6%YTD
+29.6%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
16.5How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
7.9%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
3.8%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
7.7%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.4Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
12.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
23.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.7Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Jul 15, 2026$7.45$6.21+20.0%
Q1 2026Apr 22, 2026$12.58$10.82+16.3%
Q4 2025Jan 28, 2026$3.33$3.10+7.4%
Q3 2025Oct 21, 2025$6.03$4.93+22.3%
Next earningsWed, Oct 21·consensus EPS $4.70
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$50.2B+2.6%18.1%5.3%$8.00$4.1B
Q4 FY25$49.7B+9.5%23.5%1.2%$2.47$-209.0M
Q3 FY25$50.7B+12.3%24.8%3.5%$5.32$775.0M
Q2 FY25$49.8B+14.0%26.3%5.3%$7.72$1.8B
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$197.0B$192.0B – $202.1B$27.13$25.86 – $28.4013
FY27$201.4B$196.6B – $210.4B$29.58$29.03 – $31.2114
FY28$212.4B$199.0B – $220.8B$34.00$32.15 – $36.649
FY29$214.0B$207.2B – $221.0B$40.95$39.24 – $42.694
FY30$232.2B$224.8B – $239.8B$47.89$45.90 – $49.934
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.78%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+1.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+13.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatHigh float · 216.4M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.3% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.695-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KPress release / Reg FDJun 108-K — Item 7.01: Press release / Reg FD
AI summary
8-KShareholder voteMay 138-K — Item 5.07: Shareholder vote
AI summary
8-KPress release / Reg FDMar 108-K — Item 7.01: Press release / Reg FD
8-KOfficer or director changeFeb 268-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
+ 12 other (2 10-Qs · 2 earnings 8-Ks · 2 11-Ks · 2 13Gs) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?Ballast Inc. Makes New Investment in Elevance Health, Inc. $ELVAxiom Investment Management LLC Takes $542,000 Position in Elevance Health, Inc. $ELVElevance Health, Inc. $ELV Shares Bought by Bank of America Corp DEElevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
More in Medical - Healthcare Plans
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 2 · last 7 days